cagrilintide semaglutide combination phase 3 2024 Co-formulation of and Shows Promise Against Diabetes and Obesity Cagrilintide is an amylin analogue

Both the drug's manufacturer and medical experts strongly advise against it because it can make the treatment less effective and potentially risk your health

Good communication with your healthcare team helps manage dose adjustments and any concerns that come up

If you're carb counting or using closed-loop insulin delivery, mention to your diabetes care team that you've started a GLP-1 medication so you can adjust your approach if needed

This is exactly why physician supervision and personalized nutritional guidance are not optional add-ons

For more injection guidance specific to semaglutide injection techniques , the detailed guide covers nuances for different body compositions

If you choose not to breastfeed, you can resume semaglutide immediately after giving birth